Pacific Point Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$954K Sell
10,407
-6,286
-38% -$550K 0.44% 64
2026
Q1
$1.42M Sell
16,693
-105
-0.6% -$9.36K 0.75% 36
2025
Q4
$1.33M Sell
16,798
-705
-4% -$55.3K 0.71% 45
2025
Q3
$1.4M Buy
17,503
+427
+3% +$36.4K 0.82% 42
2025
Q2
$1.55M Buy
17,076
+829
+5% +$75.7K 0.84% 31
2025
Q1
$1.52M Buy
16,247
+1,411
+10% +$126K 0.85% 27
2024
Q4
$1.28M Buy
+14,836
New +$1.42M 0.78% 35

Other funds holding CL

Pacific Point Advisors's CL Position: Q2 2026 in Review

Pacific Point Advisors reduced its Colgate-Palmolive (CL) stake by 38% in Q2 2026, selling an estimated $550K and leaving 10,407 shares worth $954K. The position accounts for 0.44% of the portfolio, ranked #64.

Pacific Point Advisors first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.55M in Q2 2025. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Pacific Point Advisors held 10,407 shares of Colgate-Palmolive worth $954K as of Q2 2026.
  • Pacific Point Advisors sold 6,286 Colgate-Palmolive shares in Q2 2026, an estimated $550K.
  • Colgate-Palmolive made up 0.44% of Pacific Point Advisors's portfolio in Q2 2026, its #64 holding.
  • Pacific Point Advisors first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Pacific Point Advisors's Colgate-Palmolive position peaked at $1.55M in Q2 2025.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Pacific Point Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.